Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
about
Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionTargeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunitiesNesfatin-1 protects dopaminergic neurons against MPP+/MPTP-induced neurotoxicity through the C-Raf-ERK1/2-dependent anti-apoptotic pathwayOlesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound.Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.The Alzheimer's disease mitochondrial cascade hypothesisNeuroprotective effects of Psoralea corylifolia Linn seed extracts on mitochondrial dysfunction induced by 3-nitropropionic acid.Mitochondria as a therapeutic target for aging and neurodegenerative diseases.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus.The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.Bioenergetic medicine.Mitochondria as a pharmacological target: magnum overview.Effect of cholinergic signaling on neuronal cell bioenergetics.Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.Mitochondria, Cybrids, Aging, and Alzheimer's Disease.The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.
P2860
Q26865358-947BCAA0-2705-4A13-96B3-71DCDE052E54Q27338799-286739CF-52A0-43F6-A304-7367514AB3DCQ30835631-2B79B841-9E9A-4150-82F0-664A6B59BDF8Q31135310-14AF7CC8-AD1E-4F27-A82A-FDDD28F16DBDQ33603263-C049A9AE-6D12-4D5F-AC36-0945F53AA9D4Q33905871-C2DE0FC9-2720-4A57-AF73-C8CA38B01ADBQ35296810-1E393A0B-FE77-4702-9C00-998CBC847C88Q35807409-D3EB2D8E-4F52-41DF-B12A-4E551E0D00F8Q35958359-66E7FCD4-B1BF-4F37-9AA7-DF8CB3CF3FC7Q37599302-5BAEF8A3-4F5F-4BEE-B84C-874DBF5FF98FQ37656554-644EC34E-168E-47FF-A448-08341D7D3C73Q37686246-F588FC34-F983-4E6B-85E5-B96680586DBAQ38084631-630F50E0-B951-4B9B-BC0A-B0DC3AFAD753Q38413032-9CF2A6E2-9DD2-4FB9-A1F6-BDD2B1F3911EQ38574670-84E823FC-7DB1-4419-A130-2E843B0F5569Q38932850-D679A460-C21C-4565-9E46-03C7B2715008Q39212503-9CD74CB0-915C-4D85-AFD5-9521296F3BE7
P2860
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
@ast
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
@en
type
label
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
@ast
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
@en
prefLabel
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
@ast
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
@en
P2860
P356
P1433
P1476
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.
@en
P2093
Russell H Swerdlow
P2860
P304
P356
10.3390/PH2030150
P577
2009-12-01T00:00:00Z